Oxcarbazepine is indicated for the treatment of partial seizures with or without secondarily generalised tonicclonic seizures.
Oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in adults and in children of 6 years of age and above.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
600 - 2,400 mg
From 300 To 1,200 mg 2 time(s) per day every day
Oxcarbazepine should be initiated with a dose of 600 mg/day (8-10 mg/kg/day) given in 2 divided doses.
If clinically indicated, the dose may be increased by a maximum of 600 mg/day at approximately weekly intervals from the starting dose to achieve the desired clinical response. Therapeutic effects are seen at doses between 600 mg/day and 2,400 mg/day.
Controlled monotherapy trials in patients not currently being treated with antiepileptic medicinal products showed 1200 mg/day to be an effective dose; however, a dose of 2,400 mg/day has been shown to be effective in more refractory patients converted from other antiepileptic medicinal products to oxcarbazepine monotherapy.
In a controlled hospital setting, dose increases up to 2,400 mg/day have been achieved over 48 hours.
Oxcarbazepine should be initiated with a dose of 600 mg/day (8-10 mg/kg/day) given in 2 divided doses.
If clinically indicated, the dose may be increased by a maximum of 600 mg/day at approximately weekly intervals from the starting dose to achieve the desired clinical response. Therapeutic responses are seen at doses between 600 mg/day and 2,400 mg/day.
Daily doses from 600 to 2,400 mg/day have been shown to be effective in a controlled adjunctive therapy trial, although most patients were not able to tolerate the 2,400 mg/day dose without reduction of concomitant antiepileptic medicinal products, mainly because of CNS-related adverse events. Daily doses above 2,400 mg/day have not been studied systematically in clinical trials.
Oxcarbazepine can be taken with or without food.
Oral
8 - 32 mg per kg of body weight
From 4 To 16 mg per kg of body weight 2 time(s) per day every day
Oxcarbazepine should be initiated with a dose of 600 mg/day (8-10 mg/kg/day) given in 2 divided doses.
If clinically indicated, the dose may be increased by a maximum of 600 mg/day at approximately weekly intervals from the starting dose to achieve the desired clinical response. Therapeutic effects are seen at doses between 600 mg/day and 2,400 mg/day.
Controlled monotherapy trials in patients not currently being treated with antiepileptic medicinal products showed 1200 mg/day to be an effective dose; however, a dose of 2,400 mg/day has been shown to be effective in more refractory patients converted from other antiepileptic medicinal products to oxcarbazepine monotherapy.
In a controlled hospital setting, dose increases up to 2,400 mg/day have been achieved over 48 hours.
Oxcarbazepine should be initiated with a dose of 600 mg/day (8-10 mg/kg/day) given in 2 divided doses.
If clinically indicated, the dose may be increased by a maximum of 600 mg/day at approximately weekly intervals from the starting dose to achieve the desired clinical response. Therapeutic responses are seen at doses between 600 mg/day and 2,400 mg/day.
Daily doses from 600 to 2,400 mg/day have been shown to be effective in a controlled adjunctive therapy trial, although most patients were not able to tolerate the 2,400 mg/day dose without reduction of concomitant antiepileptic medicinal products, mainly because of CNS-related adverse events. Daily doses above 2,400 mg/day have not been studied systematically in clinical trials.
Oxcarbazepine can be taken with or without food.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.